Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04221035 |
Title | High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN) (HR-NBL2) |
Acronym | HR-NBL2 |
Recruitment | Recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Gustave Roussy, Cancer Campus, Grand Paris |
Indications | |
Therapies | |
Age Groups: | child | adult |
Covered Countries | SWE | SVN | SVK | NOR | NLD | LTU | ITA | ISR | GRC | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CHE | BEL | AUS |